Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

DiaMedica Therapeutics (DMAC) Return on Sales (2018 - 2019)

DiaMedica Therapeutics' Return on Sales history spans 2 years, with the latest figure at 18.14% for Q2 2019.

  • For Q2 2019, Return on Sales changed N/A year-over-year to 18.14%; the TTM value through Jun 2019 reached 18.14%, changed N/A, while the annual FY2025 figure was 35.3%, 75424.0% down from the prior year.
  • Return on Sales reached 18.14% in Q2 2019 per DMAC's latest filing, down from 16.67% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 2.77% in Q3 2018 to a low of 18.14% in Q2 2019.